NR4A1 and breast cancer: With recent data about the frequency of mutations in unselected patients with breast cancer, including older patients13,14, it may be more useful to identify which patients do NOT need testing, (e.g., older patients with hormone receptor-positive breast cancer and no family history of BRCA-related cancers) rather than complicated algorithms for which patients do.